P897: UPDATED RESULTS FROM THE ONGOING PHASE 1 STUDY OF ELRANATAMAB, A BCMA TARGETED T-CELL REDIRECTING IMMUNOTHERAPY, FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

• A. Dalovisio,
• N. Bahlis,
• N. Raje,
• C. Costello,
• B. Dholaria,
• M. Solh,
• M. Levy,
• M. Tomasson,
• H. Dube,
• M. Damore,
• S. Jiang,
• C. Basu,
• A. Skoura,
• E. Chan,
• S. Trudel,
• A. Jakubowiak,
• M. Chu,
• C. Gasparetto,
• M. Sebag,
• A. Lesokhin

Affiliations

A. Dalovisio

1 Department of Hematology and Oncology, Ochsner Health, Jefferson, United States of America

N. Bahlis

2 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada

N. Raje

3 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston

C. Costello

4 Moores Cancer Center, University of California San Diego, La Jolla

B. Dholaria

5 Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville

M. Solh

6 Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta

M. Levy

7 Department of Medical Oncology, Baylor Scott and White Health, Dallas

M. Tomasson

8 Holden Comprehensive Cancer Center, University of Iowa, Iowa City

H. Dube

9 Oncology Research and Development

M. Damore

9 Oncology Research and Development

S. Jiang

10 Early Clinical Development, Pfizer, San Diego

C. Basu

10 Early Clinical Development, Pfizer, San Diego

A. Skoura

11 Early Clinical Development, Pfizer, Collegeville

E. Chan

12 Oncology Research and Development, Pfizer, South San Francisco, United States of America

S. Trudel

13 Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

A. Jakubowiak

14 Department of Medicine, University of Chicago Medical Center, Chicago, United States of America

M. Chu

15 Cross Cancer Institute, Edmonton, Canada

C. Gasparetto

16 Department of Medicine, Duke University Cancer Institute, Durham, United States of America

M. Sebag

17 Cedars Cancer Center, McGill University Health Center, Montreal, Canada

A. Lesokhin

18 Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States of America